Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial (Q37465523)

From Wikidata
Jump to navigation Jump to search
scientific article published on 20 August 2013
edit
Language Label Description Also known as
English
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
scientific article published on 20 August 2013

    Statements

    Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial (English)
    0 references
    Michael Schiff
    Michael E Weinblatt
    Robert Valente
    Gustavo Citera
    Ayanbola Elegbe
    Michael Maldonado
    Roy Fleischmann
    20 August 2013
    86-94

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit